A Trial of Montelukast for Maintenance Therapy of Eosinophilic Esophagitis in Children

NCT01458418 · clinicaltrials.gov ↗

NA

Phase

TERMINATED

Status

4

Enrollment

OTHER

Sponsor class

Stopped Inability to complete enrollment due to difficulty in finding subjects

Conditions

Eosinophilic Esophagitis

Interventions

DRUG: Montelukast
OTHER: placebo
DRUG: 5 mg Montelukast

Sponsor

Children's Mercy Hospital Kansas City